1 day ago · - Lisa Wyman brings more than 20 years of leadership and functional experience to new role of Chief Technical and Quality Officer on the Executive Team at Scholar Rock - Ted Myles, Chief Operating Officer & Chief Financial Officer, will continue to operate through transition phase to a new organizational structure.

2 days ago · CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, announced today that Lisa Wyman has been …

1 day ago · Lisa Wyman joins Scholar Rock from Generate Biomedicines, where she held the position of Chief Technical Operations Officer and was a key member of the executive leadership team.

1 day ago · Scholar Rock (), a late-stage biopharmaceutical company developing innovative treatments for spinal muscular atrophy, cardiometabolic disorders, Wednesday announced the appointment of Lisa Wyman as Chief Technical and Quality Officer.This newly created role is part of the company's strategic evolution as it prepares for its first anticipated drug approval and …

2 days ago · Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, announced today that Lisa Wyman has been appointed to the new role of Chief Technical and Quality …

1 day ago · Scholar Rock (NASDAQ: SRRK) has appointed Lisa Wyman as Chief Technical and Quality Officer (CTQO) to support the company's transformation into a fully integrated biopharma company ahead of its first expected drug approval and commercial launch in 2025. Wyman brings over 20 years of leadership experience in technical and quality operations from her roles at …

Scholar Rock Holding Corp (SRRK, Financial), a late-stage biopharmaceutical company, announced the appointment of Lisa Wyman as Chief Technical and Quality Officer (CTQO) to support its growth and transition into a fully integrated biopharma company.This strategic move comes as Scholar Rock prepares for its first expected drug approval and commercial launch in …

1 day ago · Presently, Lisa Wyman occupies the position of Vice President-Operations for Acceleron Pharma, Inc. Ms. Wyman received a graduate degree from Tufts University and an undergraduate degree from Ithaca College.

This year, I have used my training to raise funds and awareness for mental health through the Brookline Center for Community Health. I am excited to be able to run...